You Yunghun, Choi Dong Wook, Heo Jin Seok, Han In Woong, Choi Seong Ho, Jang Kee-Taek, Han Sunjong, Han Sang Hyup
Department of Surgery, Konkuk University Choongju Hospital, Konkuk University School of Medicine, Chungju, Korea.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Surg Treat Res. 2019 Jan;96(1):19-26. doi: 10.4174/astr.2019.96.1.19. Epub 2018 Dec 26.
Recent studies have suggested microscopic positive resection margin should be revised according to the presence of tumor cells within 1mm of the margin surface in resected specimens of pancreatic cancer. However, the clinical meaning of this revised margin status for R1 resection margin was not fully clarified.
From July 2012 to December 2014, the medical records of 194 consecutive patients who underwent pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head were analyzed retrospectively. They were divided into 3 groups on margin status; revised microscopic negative margin (rR0) - tumor exists more than 1 mm from surgical margin, revised microscopic positive margin (rR1) - tumor present within less than 1 mm from surgical margin, classic microscopic positive margin (cR1) - tumor is exposed to surgical margin.
There were 76 rR0 (39.2%), 100 rR1 (51.5%), and 18 cR1 (9.3%). There was significant difference in disease-free survival rates between cR1 . rR1 (8.4 months . 24.0 months, P = 0.013). Margin status correlated with local recurrence rate (17.1% in rR0, 26.0% in rR1, and 44.4% in cR1, P = 0.048). There is significant difference in recurrence at tumor bed (11.8% in rR0 . 23.0 in rR1, P = 0.050). Of rR1, adjuvant treatment was found to be an independent risk factor for local recurrence (hazard ratio, 0.297; 95% confidence interval, 0.127-0.693, P = 0.005).
Revised R1 resection margin (rR1) affects recurrence at the tumor bed. Adjuvant treatment significantly reduced local recurrence of rR1. Accordingly, adjuvant chemoradiation for rR1 group should be taken into account.
近期研究表明,在胰腺癌切除标本中,微观切缘阳性应根据切缘表面1mm内是否存在肿瘤细胞进行修正。然而,这种修正后的切缘状态对R1切除切缘的临床意义尚未完全阐明。
回顾性分析2012年7月至2014年12月期间连续194例行胰十二指肠切除术治疗胰头导管腺癌患者的病历资料。根据切缘状态将患者分为3组:修正微观切缘阴性(rR0)——肿瘤距手术切缘超过1mm;修正微观切缘阳性(rR1)——肿瘤距手术切缘小于1mm;经典微观切缘阳性(cR1)——肿瘤暴露于手术切缘。
rR0组76例(39.2%),rR1组100例(51.5%),cR1组18例(9.3%)。cR1组与rR1组的无病生存率存在显著差异(8.4个月对24.0个月,P = 0.013)。切缘状态与局部复发率相关(rR0组为17.1%,rR1组为26.0%,cR1组为44.4%,P = 0.048)。肿瘤床复发存在显著差异(rR0组为11.8%,rR1组为23.0%,P = 0.050)。在rR1组中,辅助治疗是局部复发的独立危险因素(风险比,0.297;95%置信区间,0.127 - 0.693,P = 0.005)。
修正后的R1切除切缘(rR1)影响肿瘤床复发。辅助治疗显著降低了rR1的局部复发率。因此,应考虑对rR1组进行辅助放化疗。